Livzon Pharma Releases 2025 Annual Report and AGM Documentation Online

Bulletin Express

04/23

On 23 April 2026, Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) announced that the following corporate documents are now available on both the company website (www.livzon.com.cn) and the Hong Kong Stock Exchange’s website (www.hkexnews.hk):

• 2025 Annual Report • Circular dated 23 April 2026 • Notice and Proxy Form for the 2025 Annual General Meeting • Notice and Proxy Form for the 2026 First Class Meeting of H-Shareholders

The board recommends shareholders and investors review the digital versions to ensure timely access to information. Non-registered holders experiencing difficulty with electronic access may obtain printed copies free of charge by completing the enclosed request form and sending it to the Hong Kong branch share registrar, Tricor Investor Services Ltd., at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by emailing 1513-ecom@vistra.com.

Stakeholders wishing to switch to electronic delivery must provide a functional email address through their respective banks, brokers, custodians, nominees, or HKSCC Nominees Ltd. Until a valid email address is registered, non-registered holders will continue to receive hard-copy notices of publication.

Enquiries can be directed to Tricor Investor Services’ hotline at (852) 2980 1333, Monday to Friday, 9:00 a.m. to 6:00 p.m. (excluding public holidays).

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1105246407"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1105246407\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1105246407?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-23 22:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105246407","market":"hk","top_or_hot":-1,"title":"Livzon Pharma Releases 2025 Annual Report and AGM Documentation Online","media":"Bulletin Express","content":"<p>On 23 April 2026, Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) announced that the following corporate documents are now available on both the company website (www.livzon.com.cn) and the Hong Kong Stock Exchange’s website (www.hkexnews.hk):</p>\n<p>• 2025 Annual Report  \n• Circular dated 23 April 2026  \n• Notice and Proxy Form for the 2025 Annual General Meeting  \n• Notice and Proxy Form for the 2026 First Class Meeting of H-Shareholders</p>\n<p>The board recommends shareholders and investors review the digital versions to ensure timely access to information. Non-registered holders experiencing difficulty with electronic access may obtain printed copies free of charge by completing the enclosed request form and sending it to the Hong Kong branch share registrar, Tricor Investor Services Ltd., at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by emailing 1513-ecom@vistra.com.</p>\n<p>Stakeholders wishing to switch to electronic delivery must provide a functional email address through their respective banks, brokers, custodians, nominees, or HKSCC Nominees Ltd. Until a valid email address is registered, non-registered holders will continue to receive hard-copy notices of publication.</p>\n<p>Enquiries can be directed to Tricor Investor Services’ hotline at (852) 2980 1333, Monday to Friday, 9:00 a.m. to 6:00 p.m. (excluding public holidays).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Livzon Pharma Releases 2025 Annual Report and AGM Documentation Online</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLivzon Pharma Releases 2025 Annual Report and AGM Documentation Online\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-04-23 22:43</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>On 23 April 2026, Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) announced that the following corporate documents are now available on both the company website (www.livzon.com.cn) and the Hong Kong Stock Exchange’s website (www.hkexnews.hk):</p>\n<p>• 2025 Annual Report  \n• Circular dated 23 April 2026  \n• Notice and Proxy Form for the 2025 Annual General Meeting  \n• Notice and Proxy Form for the 2026 First Class Meeting of H-Shareholders</p>\n<p>The board recommends shareholders and investors review the digital versions to ensure timely access to information. Non-registered holders experiencing difficulty with electronic access may obtain printed copies free of charge by completing the enclosed request form and sending it to the Hong Kong branch share registrar, Tricor Investor Services Ltd., at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by emailing 1513-ecom@vistra.com.</p>\n<p>Stakeholders wishing to switch to electronic delivery must provide a functional email address through their respective banks, brokers, custodians, nominees, or HKSCC Nominees Ltd. Until a valid email address is registered, non-registered holders will continue to receive hard-copy notices of publication.</p>\n<p>Enquiries can be directed to Tricor Investor Services’ hotline at (852) 2980 1333, Monday to Friday, 9:00 a.m. to 6:00 p.m. (excluding public holidays).</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01513","symbol_name":"麗珠醫藥","start_time":0,"source_url":"","article_id":"1105246407","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105246407","pubTimestamp":1776955435,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 23 April 2026, Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) announced that the following corporate documents are now available on both the company website (www.livzon.com.cn) and the Hong Kong...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01513":"丽珠医药"},"translate_title":"丽珠医药在线发布2025年年度报告及年度股东大会文件","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01513":1},"content_text":"On 23 April 2026, Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) announced that the following corporate documents are now available on both the company website (www.livzon.com.cn) and the Hong Kong Stock Exchange’s website (www.hkexnews.hk):\n• 2025 Annual Report  \n• Circular dated 23 April 2026  \n• Notice and Proxy Form for the 2025 Annual General Meeting  \n• Notice and Proxy Form for the 2026 First Class Meeting of H-Shareholders\nThe board recommends shareholders and investors review the digital versions to ensure timely access to information. Non-registered holders experiencing difficulty with electronic access may obtain printed copies free of charge by completing the enclosed request form and sending it to the Hong Kong branch share registrar, Tricor Investor Services Ltd., at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by emailing 1513-ecom@vistra.com.\nStakeholders wishing to switch to electronic delivery must provide a functional email address through their respective banks, brokers, custodians, nominees, or HKSCC Nominees Ltd. Until a valid email address is registered, non-registered holders will continue to receive hard-copy notices of publication.\nEnquiries can be directed to Tricor Investor Services’ hotline at (852) 2980 1333, Monday to Friday, 9:00 a.m. to 6:00 p.m. (excluding public holidays).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}